• Hematology and hematology/oncology public health and research issues; HR 640 Bone Marrow Failure Disease Research and Treatment Act of 2011.
• Medicare Physician Fee Schedule; Medicare Reimbursement for Drugs and Biologicals; Medicare Coverage Policies; Medicare Hospital Outpatient Payment System. Implementation of Patient Protection and Affordable Care Act.
• Hematology and Oncology drug research and approval issues. S. 296 Preserving Access to Life-Saving Medications Act.
• FY 2011 Labor, HHS, Education Appropriations bills; hematology/oncology public health and research issues.

Duration: January 1, 2009 to June 30, 2011

General Issues: Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Pharmacy, Budget/Appropriations

Spending: about $200,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2009: House of Representatives, U.S. Senate, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)